A Multicenter Phase II Study of Twice-Weekly Bortezomib plus Rituximab in Patients with Relapsed Follicular Lymphoma: Long-Term Follow-Up. (Q33436585)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A Multicenter Phase II Study of Twice-Weekly Bortezomib plus Rituximab in Patients with Relapsed Follicular Lymphoma: Long-Term Follow-Up. |
scientific article |
Statements
A Multicenter Phase II Study of Twice-Weekly Bortezomib plus Rituximab in Patients with Relapsed Follicular Lymphoma: Long-Term Follow-Up (English)
Roberto Guariglia
Raffaella Marcheselli
Luigi Marcheselli
Alberto Fragasso
Angelo Michele Carella
Francesco Angrilli
Caterina Stelitano
Gruppo Italiano Studio Linfomi (GISL)
Isabel Alvarez
Antonio Lazzaro
Stefano Sacchi